Metabolism of the Endocannabinoids, 2-Arachidonylglycerol and Anandamide, into Prostaglandin, Thromboxane, and Prostacyclin Glycerol Esters and Ethanolamides

This publication has 44 references indexed in Scilit:

• Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance
  Prostaglandins, Leukotrienes & Essential Fatty Acids, 2002
• Covalent Modification of Cyclooxygenase-2 (COX-2) by 2-Acetoxyphenyl Alkyl Sulfides, a New Class of Selective COX-2 Inactivators
  Journal of Medicinal Chemistry, 1998
• Identification of Thromboxane A2 Synthase Active Site Residues by Molecular Modeling-guided Site-directed Mutagenesis
  Journal of Biological Chemistry, 1996
• Bacterial expression and site-directed mutagenesis of two critical residues (tyrosine-151 and lysine-155) of human placental NAD+ -dependent 15-hydroxyprostaglandin dehydrogenase
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1994
• Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects
  Journal of Clinical Investigation, 1982
• Enzymatic conversion of C21 endoperoxides to thromboxanes and hyroxy acids
  Biochemical and Biophysical Research Communications, 1980
• A structural requirement for the conversion of prostaglandin endoperoxides to thromboxanes
  FEBS Letters, 1979
• Purification and characterisation of prostaglandin endoperoxide D-isomerase, a cytoplasmic, glutathione-requiring enzymE
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
• Nonenzymic reduction of prostaglandin H by lipoic acid
  Biochemistry, 1977
• HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
  The Lancet, 1977